Yuan Xie Selected Research

Non-alcoholic Fatty Liver Disease

6/2022	Silybin regulates P450s activity by attenuating endoplasmic reticulum stress in mouse nonalcoholic fatty liver disease.
1/2021	Silybin Restored CYP3A Expression through the Sirtuin 2/Nuclear Factor κ-B Pathway in Mouse Nonalcoholic Fatty Liver Disease.
3/2020	Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model.
9/2018	Curcumin regulates endogenous and exogenous metabolism via Nrf2-FXR-LXR pathway in NAFLD mice.
1/2018	Silybin inhibits NLRP3 inflammasome assembly through the NAD+/SIRT2 pathway in mice with nonalcoholic fatty liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuan Xie Research Topics

Disease

30	Neoplasms (Cancer) 01/2022 - 06/2004
11	Stomach Neoplasms (Stomach Cancer) 01/2022 - 07/2010
10	Infections 05/2022 - 07/2010
8	Inflammation (Inflammations) 10/2022 - 08/2011
7	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2014
7	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2017
5	Non-alcoholic Fatty Liver Disease 06/2022 - 01/2018
5	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2017
5	Carcinoma (Carcinomatosis) 09/2021 - 07/2010
5	Hypoxia (Hypoxemia) 01/2021 - 01/2018
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 10/2011
4	Fibrosis (Cirrhosis) 01/2019 - 10/2011
3	Obesity 10/2022 - 12/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 08/2011
3	Poisoning 08/2021 - 04/2015
3	Glioma (Gliomas) 02/2021 - 10/2015
3	Stroke (Strokes) 01/2021 - 01/2019
3	Liver Diseases (Liver Disease) 01/2021 - 11/2013
3	Fatty Liver 01/2021 - 09/2018
2	Type 2 Diabetes Mellitus (MODY) 10/2022 - 04/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 07/2022 - 06/2022
2	Body Weight (Weight, Body) 02/2022 - 04/2015
2	Pneumonia (Pneumonitis) 02/2022 - 10/2013
2	Carcinogenesis 01/2022 - 10/2011
2	Ischemic Stroke 01/2022 - 01/2020
2	Glaucoma 01/2022 - 09/2015
2	Nasopharyngeal Carcinoma 02/2020 - 01/2020
2	Metabolic Diseases (Metabolic Disease) 01/2020 - 10/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 08/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2016
2	Reperfusion Injury 01/2019 - 01/2019
2	Gallbladder Neoplasms (Gallbladder Cancer) 08/2017 - 12/2016
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 10/2022
1	Weight Loss (Weight Reduction) 02/2022
1	Idiopathic Pulmonary Fibrosis 02/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Amyloidosis 01/2022
1	Altitude Sickness (Mountain Sickness) 01/2022

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2011
10	Pharmaceutical PreparationsIBA 09/2021 - 12/2016
6	GastrinsIBA 01/2022 - 07/2010
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2011
6	MicroRNAs (MicroRNA)IBA 10/2020 - 01/2016
5	Silybin (Lagosa)IBA 06/2022 - 04/2015
4	Long Noncoding RNAIBA 07/2022 - 01/2020
4	Cytochrome P-450 CYP3AIBA 06/2022 - 11/2013
4	ParaquatIBA 08/2021 - 04/2015
3	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 01/2016
3	EnzymesIBA 05/2022 - 07/2010
3	Messenger RNA (mRNA)IBA 01/2022 - 10/2011
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2021 - 08/2017
3	ChitosanIBA 09/2021 - 12/2014
3	Cytotoxins (Cytolysins)IBA 01/2021 - 10/2011
3	ChemokinesIBA 10/2020 - 04/2016
3	Oxygen (Dioxygen)IBA 01/2019 - 11/2017
3	CurcuminIBA 11/2018 - 01/2016
2	Tryptophan (L-Tryptophan)FDA Link 10/2022 - 09/2021
2	Therapeutic UsesIBA 02/2022 - 01/2021
2	Cholecystokinin B ReceptorIBA 01/2022 - 10/2010
2	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 09/2021
2	CytokinesIBA 01/2022 - 08/2017
2	InflammasomesIBA 01/2022 - 01/2018
2	Docetaxel (Taxotere)FDA Link 12/2021 - 10/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021 - 04/2013
2	NanocapsulesIBA 09/2021 - 09/2021
2	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 09/2021 - 10/2019
2	Biological ProductsIBA 09/2021 - 01/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 08/2021 - 01/2020
2	Staphylococcal Protein A (Protein A)IBA 01/2021 - 10/2011
2	NAD (NADH)IBA 01/2021 - 01/2018
2	Sirtuin 2IBA 01/2021 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2021 - 08/2019
2	LipidsIBA 03/2020 - 01/2016
2	NestinIBA 01/2020 - 01/2017
2	HMGB1 Protein (HMG1)IBA 01/2020 - 08/2017
2	apatinibIBA 10/2019 - 10/2018
2	Peptides (Polypeptides)IBA 01/2019 - 01/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2018 - 01/2017
2	PolyphenolsIBA 09/2018 - 01/2016
2	InterferonsIBA 04/2016 - 01/2014
2	Folic Acid (Vitamin M)FDA LinkGeneric 04/2016 - 12/2014
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2014 - 02/2012
2	DDBIBA 08/2014 - 04/2012
2	Thioacetamide (Thioacetamid)IBA 04/2012 - 10/2011
2	LuciferasesIBA 10/2011 - 07/2010
1	Tight Junction ProteinsIBA 10/2022
1	indolepropionic acidIBA 10/2022
1	Cytochromes c (Cytochrome c)IBA 06/2022
1	NADP (NADPH)IBA 06/2022
1	Hydroxyproline (4 Hydroxyproline)IBA 02/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 02/2022
1	coenzyme Q10 (CoQ10)IBA 02/2022
1	TransposasesIBA 01/2022

Therapy/Procedure

14	Therapeutics 01/2022 - 08/2011
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
2	Transplantation 02/2022 - 01/2022
2	Oral Administration 11/2018 - 11/2018
2	Immunotherapy 12/2014 - 01/2014
1	Stem Cell Transplantation 02/2022